1-5 of 5
Thomas Blankenstein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus

Ioannis Gavvovidis, Matthias Leisegang, Gerald Willimsky, Natalie Miller, Paul Nghiem, Thomas Blankenstein
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3644–3655.
https://doi.org/10.1158/1078-0432.CCR-17-2661
Published: 31 July 2018
View article titled, Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus
Open the PDF for Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus in another window
Includes: Supplementary data
Journal Articles

T-cell Receptors for Clinical Therapy: In Vitro Assessment of Toxicity Risk

Andre Kunert, Matthias Obenaus, Cor H.J. Lamers, Thomas Blankenstein, Reno Debets
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (20): 6012–6020.
https://doi.org/10.1158/1078-0432.CCR-17-1012
Published: 12 October 2017
View article titled, T-cell Receptors for Clinical Therapy: <em>In Vitro</em> Assessment of Toxicity Risk
Open the PDF for T-cell Receptors for Clinical Therapy: <em>In Vitro</em> Assessment of Toxicity Risk in another window
Journal Articles

Molecular Pathways: Comparing the Effects of Drugs and T Cells to Effectively Target Oncogenes

Kathleen Anders, Thomas Blankenstein
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 320–326.
https://doi.org/10.1158/1078-0432.CCR-12-3017
Published: 16 January 2013
View article titled, Molecular Pathways: Comparing the Effects of Drugs and T Cells to Effectively Target Oncogenes
Open the PDF for Molecular Pathways: Comparing the Effects of Drugs and T Cells to Effectively Target Oncogenes in another window
Journal Articles

T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy

Matthias Leisegang, Adriana Turqueti-Neves, Boris Engels, Thomas Blankenstein, Dolores J. Schendel, Wolfgang Uckert, Elfriede Noessner
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (8): 2333–2343.
https://doi.org/10.1158/1078-0432.CCR-09-2897
Published: 14 April 2010
View article titled, T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy
Open the PDF for T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy in another window
Includes: Supplementary data
Journal Articles

Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs

Bernhard Frankenberger, Heike Pohla, Elfriede Noessner, Gerald Willimsky, Britta Papier, Antonio Pezzutto, Joachim Kopp, Ralph Oberneder, Thomas Blankenstein, Dolores J. Schendel
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (5): 1733–1742.
https://doi.org/10.1158/1078-0432.CCR-04-1883
Published: 08 March 2005
View article titled, Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs
Open the PDF for Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs in another window